Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity
Publication
, Other
Atukorale, PU; Raghunathan, SP; Raguveer, V; Moon, TJ; Zheng, C; Bielecki, PA; Wiese, ML; Goldberg, AL; Covarrubias, G; Hoimes, CJ; Karathanasis, E
March 31, 2023
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Atukorale, P. U., Raghunathan, S. P., Raguveer, V., Moon, T. J., Zheng, C., Bielecki, P. A., … Karathanasis, E. (2023). Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity. https://doi.org/10.1158/0008-5472.22421333.v1
Atukorale, Prabhani U., Shruti P. Raghunathan, Vanitha Raguveer, Taylor J. Moon, Carolyn Zheng, Peter A. Bielecki, Michelle L. Wiese, et al. “Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity,” March 31, 2023. https://doi.org/10.1158/0008-5472.22421333.v1.
Atukorale PU, Raghunathan SP, Raguveer V, Moon TJ, Zheng C, Bielecki PA, et al. Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity. 2023.
Atukorale, Prabhani U., et al. Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity. 31 Mar. 2023. Crossref, doi:10.1158/0008-5472.22421333.v1.
Atukorale PU, Raghunathan SP, Raguveer V, Moon TJ, Zheng C, Bielecki PA, Wiese ML, Goldberg AL, Covarrubias G, Hoimes CJ, Karathanasis E. Supplementary Data from Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity. 2023.